Gestational Trophoblastic Disease: an Analysis Focused on Social Determinants of Health
Keywords:Health Social Determinants, Gestational Trophoblastic Neoplasms, Health Care Inequalities
AbstractBackground: Cancer causes are varied and interrelated. It can be internal to the body, related to genetic aspects or external to the body which relates to the environment and living habits, as well as social disparities in which individuals are inserted. By realizing that social stratification exposes individuals to different risks, and therefore to a higher or lower vulnerability, which is directly related to the social context in which the individual is inserted, this study aims to understand the relationship between the social determinants of health and Gestational trophoblastic disease, according to the conceptual framework of Dahlgren and Whitehead.
Methods: A descriptive study whose population was comprised of the medical records of women diagnosed with GTD. It was held in an obstetrical clinic of a Brazilian Northeast maternity of reference. The period was from June to August 2015. 119 medical records of women with GTD were identified between the years 2012-2013. To understand the relationship between the SDH and the factors related to GTD it was adopted the conceptual framework of Dahlgren and Whitehead.
Findings: For each layer of the framework was made a correlation with the data found among the woman. About the first layer it was observed that the prevalence of GTD cases occurred among women aged between 13 and 19, corresponding to 49.9% (n = 59) of the women analysed. Related to the second layer, it was found that there was prevalence of oral contraceptive use with 32.8% (n = 39) of cases. The marital status that prevailed among women was single with 42% (n = 50). About the third layer it was not provided information related to social and community networks on the medical records. According to the fourth layer, the prevalent education level was less than 8 years of study (48.7%). Regarding to occupation, 38.7% (n = 46) of women were housewives. Related to the salary, 6.7% (n = 8) of women indicated have up to 1 minimum wage as income. Most women live on the countryside (60.5%). Related to the fifth layer it was found on the literature the need of intersectorial actions to solve the health inequities to promote an appropriate enviroment of health.
Conclusion: It is understood that GTD has multifactorial etiology. Despite of the major influence of the genetic factor, the influence of social determinants on health outcomes of these women cannot be neglected. Therefore, it is essential for health professionals to understand the individuals in their entirety considering the various aspects that involve their lives.
Instituto Nacional do CÃ¢ncer (INCA). CÃ¢ncer: o que o cÃ¢ncer? [Internet]. Rio de Janeiro, 2015. Available in: http://www HYPERLINK "http://www1.inca.gov.br/conteudo_view.asp?id=322"
Ngan HYS, Seckl MJ, Berkowitz RS, Xiang Y, Golfier F, Sekharan PK, et al. Figo Cancer Report 2015: Update on the diagnosis and management of gestational trophoblastic disease. International Journal of Gynecology and Obstetrics. 2015; 131: S123â€“6.
Wunsch FV, Antunes JLF, Boing AF, Lorenzi RL. Perspectivas da investigaÃ§Ã£o sobre determinantes sociais em cÃ¢ncer. Physis Rev SaÃºde Coletiva. 2008: 18(3) 427-50.
Brasil. GlossÃ¡rio temÃ¡tico: promoÃ§Ã£o da saÃºde. Secretaria-Executiva. Secretaria de VigilÃ¢ncia em SaÃºde. MinistÃ©rio da SaÃºde; 2012.
Badziak RPF, Moura VEV. Determinantes sociais da saÃºde: um conceito para efetivaÃ§Ã£o do direito Ã saÃºde. Rev SaÃºde PÃºblica. 2010; 3(1): 69-79.
Dahlgren G, Whitehead M. Policies and Strategies to Promote Social Equity in Health. Stockholm. Sweden: Institute for Futures Studies; 1991.
Buss PM, Pellegrini AF. A saÃºde e seus Determinantes sociais. Rev SaÃºde Coletiva. 2007; 17(1): 77-93.
Geib LTC. Determinantes sociais da saÃºde do idoso. CiÃªncia & SaÃºde Coletiva. 2012; 17(1): 123-33.
Brasil. As causas sociais das iniquidades em saÃºde no Brasil. RelatÃ³rio final da comissÃ£o nacional sobre determinantes sociais da saÃºde. ComissÃ£o Nacional de Determinantes Sociais da SaÃºde; 2008.
Sobral A, Freitas CM. Modelo de organizaÃ§Ã£o de indicadores para operacionalizaÃ§Ã£o dos determinantes socioambientais da saÃºde. SaÃºde Soc SÃ£o Paulo. 2010; 19(1): 35-47.
Souza DO, Silva SEV, Silva NO. Determinantes sociais da saÃºde: reflexÃµes a partir das raÃzes da â€œquestÃ£o socialâ€. SaÃºde Soc SÃ£o Paulo. 2013; 22(1): 44-56.
Mattei VED, Carnelli L, Bernardi M, Pagani BE, Zucchi P, Lavezzari L, et al. An Investigative Study into Psychological and Fertility Sequelae of Gestational Trophoblastic Disease: The Impact on Patientsâ€™ Perceived Fertility, Anxiety and Depression. PLoS One. 2015; 10(6): e0128354.
Almasi A, Almassinokiani F, Akbari P. Frequency of Molar Pregnancies in Health Care Centers of Tehran, Iran. J Reprod Infertil. 2014; 14(3): 157-60.
Stevens FT, Katzorke N, Tempfer C, Kreimer U, Bizjak GI, Fleisch MC, et al. Gestational Trophoblastic Disorders: An Update in 2015. Geburtshilfe Frauenheilkd. 2015; 75(10): 1043â€“50.
Rachad M, Chaara H, Fdili FZ, Bouguern H, Melhouf A. Ovarian hyperstimulation syndrome in a spontaneous pregnancy with invasive mole: report of a case. Pan Afr Med J. 2011; 9: 23.
Alper MM, Smith LP, Sills ES. Ovarian hyperstimulation syndrome: current views on pathophysiology, risk factors, prevention, and management. J Exp Clin Assist Reprod. 2009; 6:3.
Castro EC, Borges ALF, Rezende KN, Amaral WN. Antral follicle count in predicting appropriate dose of gonatrotropin in vitro fertilization cycles. Reprod Clim. 2014; 29(3): 136-42.
Martins AMBB, Zioni F. ComunicaÃ§Ã£o do conhecimento em determinantes sociais de saÃºde: uma revisÃ£o da produÃ§Ã£o cientÃfica. Rev Tempus Actas SaÃºde Col. 2013; 7(4): 223-38.
Seckl MJ, Sebire NJ, Berkowitz RS. Gestational trophoblastic disease. The Lancet. 2010; 376: 717-29.
Martins ARB, Ouro TA, Neri M. Compartilhando vivÃªncias: contribuiÃ§Ã£o de um grupo de apoio para mulheres com cÃ¢ncer de mama. Rev SBPH. 2015; 18(1): 131-51.
Cardoso DH, Muniz RM, GuimarÃ£es SRL, Viegas AC, Pinto BK, Laroque MF. Viver com cÃ¢ncer: a percepÃ§Ã£o de pacientes oncolÃ³gicos. J Nurs Health. 2012; 2(2):462-74.
GuimarÃ£es AQ, Almeida ME. Os Jovens e o mercado de Trabalho: EvoluÃ§Ã£o e Desafios da PolÃtica de Emprego no Brasil. Temas de AdministraÃ§Ã£o PÃºblica. 2013; 8(2): 1-26.
Silva MAM, Cavalcante AES, TeodÃ³sio TBT. Necessidades Psicossociais de uma Gestante Adolescente de Alto Risco Hospitalizada: Estudo de Caso ClÃnico com Base na Teoria de Wanda Horta. Essentia Sobral. 2014; 16(1): 167-81.
Moratoya EE, Carvalhaes GC, Wander AE, Almeida LMMC. MudanÃ§as no padrÃ£o de consumo alimentar no Brasil e no mundo. Revista de PolÃtica agrÃcola. 2013; 22(1): 72-84.
Botelho NM, GÃ³es ASO, Silva LMG. Aspectos clÃnicos da doenÃ§a trofoblÃ¡stica gestacional. Revista Paraense de Medicina. 2012; 26(3): 1-5.
Tse KY, Chan KKL, Tam KF, Ngan HYS. Current management of gestational trophoblastic disease. Obstetrics, Gynaecology and Reproductive Medicine. 2014; 25, (1): 12-21.
Hoffman BL, Schorge JO, Halvorson LM, Bradshaw KD, Schaffer JI, Cunningham FG. Ginecologia de Williams. 1th ed. Mcgraw - Hill; 2011.
GuarÃ¡ JP, Oliveira AGC, Martins MG. Neoplasias TrofoblÃ¡sticas Gestacionais e importÃ¢ncia do seguimento pÃ³s molar. Rev Pesq SaÃºde. 2010; 11(3), 50-3.
MaestÃ¡ I, Braga A. Desafios do tratamento de pacientes com doenÃ§a trofoblÃ¡stica gestacional. Rev Bras Ginecol Obstet. 2012; 34(4): 143-6.
Hoekstra AV, Lurain JR, Rademaker AW, Schink JC. Gestational trophoblastic neoplasia: Treatment outcomes. Obstet Gynecol. 2008; 112(2): 251-8.
Ferraz L, Lopes PF, Amim J, Montenegro CAB, Braga A. AtualizaÃ§Ã£o no diagnÃ³stico e tratamento da gravidez molar. JBM. 2015; 103(2): 6-12.
Pellegrini FA. IntervenÃ§Ãµes individuais vs. intervenÃ§Ãµes populacionais. Determinantes sociais da saÃºde: portal e observatÃ³rio sobre iniquidades em saÃºde. 2011 august 16.
Cintio ED, Parazzini F, Rosa CC, Hatenoud L, Benzi G. The epidemiology of gestational trofoblastic disease. Gen Diag Pathol. 1997; 143: 103-8.
Ozalp SS. Regional perspectives on gestational trophoblastic disease in Turkey. J Reprod Med. 2008; 3: 639-42.
Berkowitz RS, Goldstein DP. Current advances in the management of gestational trophoblastic disease. Gynecol Oncol. 2013; 128(1): 3-5.
Santos RS, Prates ECPM. Mortalidade e assistÃªncia oncolÃ³gica no Rio de Janeiro: cÃ¢ncer de mama e colo uterino. Esc Anna Nery Rev Enferm. 2011; 15(2): 410-6.
Marmot M, Sharon F, Bell R, Houweling TAJ, Taylor S. Social determinants of health inequalities. The Lancet. 2008; 365: 1099â€“104.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under aÂ Creative Commons Attribution LicenseÂ that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (SeeÂ The Effect of Open AccessÂ and Benefits of Publishing Open Access).